Shanmugam Muthusamy
SEC CIK 1870913 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | HEAD OF R, D, COO-NOVITIUM OPS, Dir | 101.1K | $276.5K | $63.25M | 38 | 2021-11-19 | 2026-02-26 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
| 13 | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | — | — |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-26 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | A - Grant | $77.15 | +11.1K | 101.1K | +12% | +$857.6K | |
| 2026-02-13 | 2026-02-11 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | F - Tax | $76.25 | -2,898 | 89.9K | -3% | -$221.0K | |
| MI | 2025-08-22 | 2025-08-20+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $90.36 | -100.0K | 431.9K | -19% | -$9.04M |
| MI | 2025-08-18 | 2025-08-14+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $88.25 | -100.0K | 531.9K | -16% | -$8.82M |
| I | 2025-05-13 | 2025-05-09 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $76.83 | -700 | 631.9K | -0.1% | -$53.8K |
| M | 2025-02-18 | 2025-02-12 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | A - Grant | $0.00 | +23.9K | 92.6K | +35% | $0 |
| I | 2024-07-19 | 2024-07-18 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $62.00 | -2,743 | 632.6K | -0.4% | -$170.1K |
| MI | 2024-07-17 | 2024-07-15+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $63.73 | -47.3K | 649.6K | -7% | -$3.01M |
| I | 2024-06-24 | 2024-06-21 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $58.90 | -20.0K | 682.6K | -3% | -$1.18M |
| MI | 2024-06-20 | 2024-06-17+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $60.59 | -30.0K | 702.6K | -4% | -$1.82M |
| I | 2024-05-21 | 2024-05-20 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $61.81 | -12.9K | 732.6K | -2% | -$794.6K |
| MI | 2024-05-17 | 2024-05-15+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $64.37 | -37.1K | 745.5K | -5% | -$2.39M |
| MI | 2024-04-22 | 2024-04-18+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $65.10 | -27.2K | 799.4K | -3% | -$1.77M |
| MI | 2024-04-17 | 2024-04-15+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $65.91 | -22.8K | 825.2K | -3% | -$1.50M |
| I | 2024-03-11 | 2024-03-08 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $67.17 | -10.0K | 832.6K | -1% | -$671.7K |
| MI | 2024-03-07 | 2024-03-05+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $65.77 | -40.0K | 842.6K | -5% | -$2.63M |
| 2024-03-01 | 2024-02-29 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | F - Tax | $67.67 | -1,122 | 68.7K | -2% | -$75.9K | |
| M | 2024-02-16 | 2024-02-14 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | A - Grant | $0.00 | +22.4K | 69.8K | +47% | $0 |
| MI | 2024-01-23 | 2024-01-19+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $56.17 | -25.2K | 882.6K | -3% | -$1.42M |
| MI | 2024-01-18 | 2024-01-16+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $55.29 | -24.8K | 907.8K | -3% | -$1.37M |
| MI | 2023-12-19 | 2023-12-15+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $52.55 | -50.0K | 957.6K | -5% | -$2.63M |
| MAI | 2023-11-20 | 2023-11-14+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $53.00 | -37.0K | 995.6K | -4% | -$1.96M |
| I | 2023-11-20 | 2023-11-17 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $51.00 | -13.0K | 982.6K | -1% | -$663.0K |
| MI | 2023-11-16 | 2023-11-14+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $53.00 | -36.2K | 1.00M | -3% | -$1.92M |
| MI | 2023-10-19 | 2023-10-17+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $57.75 | -25.0K | 1.05M | -2% | -$1.44M |
| MI | 2023-10-17 | 2023-10-13+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $57.96 | -25.0K | 1.06M | -2% | -$1.45M |
| MI | 2023-09-19 | 2023-09-15+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $61.81 | -50.0K | 1.08M | -4% | -$3.09M |
| MI | 2023-08-30 | 2023-08-28+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $63.22 | -50.0K | 1.13M | -4% | -$3.16M |
| MI | 2023-08-16 | 2023-08-14+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $61.35 | -50.0K | 1.20M | -4% | -$3.07M |
| MI | 2023-07-21 | 2023-07-19+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $52.02 | -23.5K | 1.23M | -2% | -$1.22M |
| MI | 2023-07-18 | 2023-07-14+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $51.02 | -26.5K | 1.26M | -2% | -$1.35M |
| MAI | 2023-06-23 | 2023-06-20+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $51.70 | -50.0K | 1.32M | -4% | -$2.58M |
| M | 2023-06-22 | 2023-06-20+ | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $51.75 | -40.0K | 20.9K | -66% | -$2.07M |
| M | 2023-04-04 | 2023-02-28 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | A - Grant | $0.00 | +28.9K | 47.4K | +157% | $0 |
| I | 2022-03-21 | 2022-03-17 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | P - Purchase | $27.65 | +5,000 | 5,000 | New | +$138.2K |
| 2022-03-21 | 2022-03-17 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | P - Purchase | $27.65 | +5,000 | 18.5K | +37% | +$138.2K | |
| I | 2021-11-23 | 2021-11-19 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | A - Grant | — | +1.33M | 1.33M | New | — |
| 2021-11-23 | 2021-11-19 | ANIP | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | A - Grant | — | +13.5K | 13.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations